Market Overview

Arbutus Biopharma Corporation (ABUS)

2.94 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.25
1.491M



Q4 2020
Pre-Market
EPS:
REV:
-0.46
1.618M



Q3 2020
Pre-Market
EPS:
REV:
-0.73
3.1M



Q2 2020
Pre-Market
EPS:
REV:
-0.46
700K
-0.24
1.74M
-0.25
1.514M
-4.17%
-12.99%
Q1 2020
Pre-Market
EPS:
REV:
-0.47
700K
-0.39
220K
-0.25
1.491M
35.9%
577.73%
Q4 2019
Pre-Market
EPS:
REV:
-0.37
1.6M
-0.39
220K
-0.46
1.618M
-17.95%
635.45%
Q3 2019
Pre-Market
EPS:
REV:
-0.30
1.6M

-0.73
3.1M

Q2 2019
Pre-Market
EPS:
REV:
-0.44
1.2M
-0.39
220K
-0.46
700K
-17.95%
218.18%
Q1 2019
After-Hours
EPS:
REV:
-0.36
1.4M
-0.39
220K
-0.47
700K
-20.51%
218.18%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!